Chimeric antagonist anth1
Details for Australian Patent Application No. 2003223832 (hide)
International Classifications
Event Publications
7 August 2003 Complete Application Filed
Priority application(s): CU2002/0095 10.05.02 CU
15 January 2004 Application Open to Public Inspection
Published as AU-B-2003223832
19 February 2009 Application Accepted
Published as AU-B-2003223832
11 June 2009 Corrigenda
Applications OPI - Name Index Under the Name Centro de Ingenieria Genetica y Biotecnologia, Application No. 2003223832, under INID (43) correct the Publication Date to read 24 November 2003
18 June 2009 Standard Patent Sealed
2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003223833-METHOD FOR RE-ROUTING A COMMUNICATION LINK INCLUDING SEVERAL RADIO COMMUNICATION SYSTEMS
2003223831-Specific antibody fragments for the human carcinoembryonic antigen (CEA)
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser
